Company / PP&E (Net)
Organogenesis Holdings Inc. PP&E (Net) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$103.7M
FY2025
5-year range
$79.2M / $116.2M
FY2021-FY2025
Trend
+16.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $116M to $104M over the past 2 years.
Based on SEC 10-K filings.
$104M in FY2025 with a 5-year CAGR of +11.5%.
Declined from $116M to $104M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- +11.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +11.5%, indicating consistent growth.
- In FY2025, pp&e (net) increased 16.4% year-over-year.
- Peak pp&e (net) was recorded in FY2023.
- Lowest pp&e (net) in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $103.7M | +16.4% |
| FY2024 | $89.1M | -23.3% |
| FY2023 | $116.2M | +13.4% |
| FY2022 | $102.5M | +29.4% |
| FY2021 | $79.2M | +31.8% |
| FY2020 | $60.1M | +27.3% |
| FY2019 | $47.2M | +19.1% |
| FY2018 | $39.6M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026